Niki BioSolutions, Inc. Equity Method Investment, Other than Temporary Impairment
Niki BioSolutions, Inc. (NIKI) reported Equity Method Investment, Other than Temporary Impairment of $77.20 thousand for the 9-month period ending 2025-09-30, per its 6-K filed 2026-01-22.
Financial Statements › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2026-01-22
- Niki BioSolutions, Inc. equity method investment, other than temporary impairment for the quarter ending 2025-09-30 was $0.00.
| Period end | Equity Method Investment, Other than Temporary Impairment 3 month | Equity Method Investment, Other than Temporary Impairment 6 month | Equity Method Investment, Other than Temporary Impairment 9 month | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2026-01-22 | $77.20K 6-K · filed 2026-01-22 | ||
| 2025-06-30 | $77.20K 6-K · filed 2025-10-08 | |||
| 2024-12-31 | $77.20K 6-K · filed 2026-01-22 | |||
| 2024-06-30 | $77.20K 6-K · filed 2024-12-20 | |||
| 2023-12-31 | $77.20K 20-F · filed 2025-04-30 |